Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma

This publication has 45 references indexed in Scilit:

• Bisphosphonates: new therapeutic agents for the treatment of bone tumors
  Trends in Molecular Medicine, 2004
• Successful Management of a Widespread Osteosarcoma
  Medical Principles and Practice, 2003
• Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group
  Journal of Clinical Oncology, 2003
• Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells
  The Journal of Experimental Medicine, 2003
• Bisphosphonates Pamidronate and Zoledronic Acid Stimulate Osteoprotegerin Production by Primary Human Osteoblasts
  Biochemical and Biophysical Research Communications, 2002
• Zoledronic Acid
  Drugs, 2001
• Adjuvant Chemotherapy of High-Grade Osteosarcoma of the Extremity
  Clinical Orthopaedics and Related Research, 1991
• Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the rat
  Clinical & Experimental Metastasis, 1990
• Basis and New Developments in the Field of Oxazaphosphorines
  Cancer Investigation, 1988
• Studies of bone and soft‐tissue tumours induced in rats with radioactive cerium chloride
  International Journal of Cancer, 1977